Actively Recruiting
Hydroxychloroquine in Type 2 Diabetes During Pregnancy
Led by National University of Malaysia · Updated on 2025-06-12
56
Participants Needed
1
Research Sites
144 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to compare the use of hydroxychloroquine as an adjunct to the current treatment of pregnant women with Type 2 diabetes mellitus. The main questions it aims to answer are: * Does hydroxychloroquine improve the pregnancy outcomes in women with type 2 diabetes during pregnancy? * Does hydroxychloroquine improve the inflammatory markers in women with type 2 diabetes during pregnancy? Participants will be randomised into the intervention and control group. The control group will be on standard treatment where as the intervention group will receive hydroxychloroquine as an adjunct of standard treatment
CONDITIONS
Official Title
Hydroxychloroquine in Type 2 Diabetes During Pregnancy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Singleton pregnancy
- Pregnant women with a confirmed diagnosis of type 2 Diabetes Mellitus
- Age between 20 and 45 years
You will not qualify if you...
- Autoimmune diseases such as Systemic Lupus Erythematosus or rheumatic disease
- Chronic kidney disease
- Fetal anomaly
- Women on steroid therapy
- Diabetic retinopathy
- Known thalassaemia or thalassaemia carrier
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Antenatal clinic, UKM Medical Centre
Cheras, Kuala Lumpur, Malaysia, 56000
Actively Recruiting
Research Team
R
Rahana Abdul Rahman, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here